Julia Schroder
Overview
Explore the profile of Julia Schroder including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
33
Citations
496
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Linke C, von Hanisch T, Schroder J, Dammermann W, Deckert P, Reinwald M, et al.
Cancers (Basel)
. 2024 Nov;
16(22).
PMID: 39594753
Background: Improving precision medicine in chemotherapy requires highly sensitive and easily applicable diagnostic tools. In addition, non-invasive molecular real-time monitoring of cytotoxic response is highly desirable. Here, we employed the...
2.
Schroder J, Dinse H, Jahre L, Skoda E, Stettner M, Kleinschnitz C, et al.
Telemed J E Health
. 2024 May;
30(8):2194-2202.
PMID: 38814744
Post-COVID-19 is an increasing chronic disease for which potential treatment options require further development and examination. A well-established approach to symptom management in post-COVID-19 patients could be e-Health interventions. To...
3.
Marsall M, Dinse H, Schroder J, Skoda E, Teufel M, Bauerle A
JMIR Form Res
. 2024 Apr;
8:e52189.
PMID: 38662429
Background: The eHealth Literacy Scale (eHEALS) is a widely used instrument for measuring eHealth literacy (eHL). However, little is known so far about whether the instrument is valid for the...
4.
Schroder J, Calligaris-Maibach R, Beer H, Wiggli B
Inn Med (Heidelb)
. 2023 Aug;
65(3):286-289.
PMID: 37548668
Nocardiosis is a rare disease that occurs primarily in patients with predisposing factors (immunosuppression/chronic lung disease). It is caused by aerobic, Gram-positive bacteria that are ubiquitous in soil. Cutaneous and...
5.
Hess T, Maj C, Gehlen J, Borisov O, Haas S, Gockel I, et al.
EBioMedicine
. 2023 Jul;
94:104709.
PMID: 37480624
No abstract available.
6.
Hader A, Schauble S, Gehlen J, Thielemann N, Buerfent B, Schuller V, et al.
Nat Commun
. 2023 Jun;
14(1):3239.
PMID: 37277347
Innate immune responses vary by pathogen and host genetics. We analyze quantitative trait loci (eQTLs) and transcriptomes of monocytes from 215 individuals stimulated by fungal, Gram-negative or Gram-positive bacterial pathogens....
7.
Schroder J, Bauerle A, Jahre L, Skoda E, Stettner M, Kleinschnitz C, et al.
Ther Adv Neurol Disord
. 2023 May;
16:17562864231175730.
PMID: 37255668
Background: Post-COVID-19 syndrome is a new and debilitating disease without adequate treatment options. eHealth could be a reasonable approach for symptom management. Objectives: This study aims to evaluate the acceptance...
8.
Hess T, Maj C, Gehlen J, Borisov O, Haas S, Gockel I, et al.
EBioMedicine
. 2023 May;
92:104616.
PMID: 37209533
Background: Gastric cancer (GC) is clinically heterogenous according to location (cardia/non-cardia) and histopathology (diffuse/intestinal). We aimed to characterize the genetic risk architecture of GC according to its subtypes. Another aim...
9.
Schroder J, Chegwidden L, Maj C, Gehlen J, Speller J, Bohmer A, et al.
Gut
. 2022 Jul;
72(4):612-623.
PMID: 35882562
Objective: Oesophageal cancer (EC) is the sixth leading cause of cancer-related deaths. Oesophageal adenocarcinoma (EA), with Barrett's oesophagus (BE) as a precursor lesion, is the most prevalent EC subtype in...
10.
Degenhardt F, Ellinghaus D, Juzenas S, Lerga-Jaso J, Wendorff M, Maya-Miles D, et al.
Hum Mol Genet
. 2022 Jul;
31(23):3945-3966.
PMID: 35848942
Given the highly variable clinical phenotype of Coronavirus disease 2019 (COVID-19), a deeper analysis of the host genetic contribution to severe COVID-19 is important to improve our understanding of underlying...